Cargando…

Understanding Laboratory Testing for SARS-CoV-2

The SARS-CoV-2 pandemic has impacted millions of lives worldwide. Molecular assays and serological tests have been approved under EUA (emergency use authorization) by the FDA (food and drug administration), given these unprecedented times. These tests are not only critical for confirming the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Ritu, Blumberg, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145134/
https://www.ncbi.nlm.nih.gov/pubmed/33946855
http://dx.doi.org/10.3390/children8050355
_version_ 1783697105717559296
author Cheema, Ritu
Blumberg, Dean A.
author_facet Cheema, Ritu
Blumberg, Dean A.
author_sort Cheema, Ritu
collection PubMed
description The SARS-CoV-2 pandemic has impacted millions of lives worldwide. Molecular assays and serological tests have been approved under EUA (emergency use authorization) by the FDA (food and drug administration), given these unprecedented times. These tests are not only critical for confirming the clinical diagnosis and making therapeutic decisions but also play an important role in the understanding of the epidemiology of the pandemic. There is limited experience with currently available tests and differences may exist among tests even using similar technology. The focus of this review is to improve clinicians’ understanding of SARS-CoV-2 test procedures including their limitations. We discuss the impact of different host and environmental factors on test results.
format Online
Article
Text
id pubmed-8145134
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81451342021-05-26 Understanding Laboratory Testing for SARS-CoV-2 Cheema, Ritu Blumberg, Dean A. Children (Basel) Opinion The SARS-CoV-2 pandemic has impacted millions of lives worldwide. Molecular assays and serological tests have been approved under EUA (emergency use authorization) by the FDA (food and drug administration), given these unprecedented times. These tests are not only critical for confirming the clinical diagnosis and making therapeutic decisions but also play an important role in the understanding of the epidemiology of the pandemic. There is limited experience with currently available tests and differences may exist among tests even using similar technology. The focus of this review is to improve clinicians’ understanding of SARS-CoV-2 test procedures including their limitations. We discuss the impact of different host and environmental factors on test results. MDPI 2021-04-29 /pmc/articles/PMC8145134/ /pubmed/33946855 http://dx.doi.org/10.3390/children8050355 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Cheema, Ritu
Blumberg, Dean A.
Understanding Laboratory Testing for SARS-CoV-2
title Understanding Laboratory Testing for SARS-CoV-2
title_full Understanding Laboratory Testing for SARS-CoV-2
title_fullStr Understanding Laboratory Testing for SARS-CoV-2
title_full_unstemmed Understanding Laboratory Testing for SARS-CoV-2
title_short Understanding Laboratory Testing for SARS-CoV-2
title_sort understanding laboratory testing for sars-cov-2
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145134/
https://www.ncbi.nlm.nih.gov/pubmed/33946855
http://dx.doi.org/10.3390/children8050355
work_keys_str_mv AT cheemaritu understandinglaboratorytestingforsarscov2
AT blumbergdeana understandinglaboratorytestingforsarscov2